Triangel Scientific

Triangel Scientific is a biotechnology company dedicated to the advancement of regenerative medicine, specifically targeting cardiovascular diseases. The company utilizes a proprietary 3D bioprinting platform to engineer functional heart tissues and patches designed to restore cardiac function following myocardial infarction. Founded by Dr. Y. James Kang, the organization integrates expertise in stem cell biology, toxicology, and materials science to develop biocompatible solutions for heart failure. Their lead programs are currently in the pre-clinical phase, focusing on the safety and integration of bioengineered constructs in animal models. Triangel Scientific aims to address the global burden of heart disease by providing alternatives to traditional organ transplantation.